Back to UBS Group AG UBS Group AG

CRVOCRVO
Showing 8 of 9 quarters

Position history for UBS Group AGUBS Group AG's holdings in CERVOMED INC

UBS Group AG holds 992 shares of CRVO (CERVOMED INC), worth $3,075 as of 2026-Q2. The position was decreased (-81.1% shares).

Current Value

$3,075

Current Shares

992

Total Value Change

-$33,965

Total Shares Change

-1,545

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
992
-81.1%
$3,0750.0%$3.10
0
2026-Q1
Increased
5,239
+402.3%
$20,6410.0%$4.01
21
2025-Q4
Decreased
1,043
-69.1%
$8,2400.0%$7.98
0
2025-Q3
Decreased
3,376
-39.6%
$27,3120.0%$8.08
0
2025-Q2
Decreased
5,593
-17.6%
$35,1530.0%$6.05
0
2025-Q1
Decreased
6,787
-84.3%
$62,1010.0%$9.48
0
2024-Q4
Increased
43,365
+1609.3%
$101,4740.0%$2.39
24
2024-Q3
Increased
2,537
+55.3%
$37,0400.0%$15.13
19

Other major holders of CRVO: RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used